Listed

OptimizeRx Corp

OPRXNasdaqCIK 1448431IndustrialsFiscal year ends Dec 31

Reports and events: 449 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

OptimizeRx Corp, Reports and events
FiledFormWhat it isAccession number
2026-08-1320:06 ET10-QQuarterly reportPeriod 2026-06-300001448431-26-000016
2026-08-1220:07 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001448431-26-000014
2026-06-1220:10 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001213900-26-068272
2026-06-0520:10 ET8-K5.02 Departure or appointment of officers or directors0001213900-26-065810
2026-05-1320:04 ET10-QQuarterly reportPeriod 2026-03-310001448431-26-000011
2026-05-1220:07 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001448431-26-000009
2026-04-3011:15 ETDEF 14AProxy statementPeriod 2026-06-090001213900-26-049698
2026-04-0921:46 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-26-041604
2026-03-3021:29 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001448431-26-000007
2026-03-1220:03 ET10-KAnnual reportPeriod 2025-12-310001448431-26-000005
2026-03-0521:09 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001448431-26-000002
2025-11-0721:03 ET10-QQuarterly reportPeriod 2025-09-300001448431-25-000020
2025-11-0621:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001448431-25-000018
2025-08-1911:44 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-25-078162
2025-08-0820:02 ET10-QQuarterly reportPeriod 2025-06-300001448431-25-000012
2025-08-0720:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001448431-25-000010
2025-06-2411:45 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-25-056908
2025-06-1620:29 ET8-K5.07 Shareholder vote results0001213900-25-054784
2025-05-1320:04 ET10-QQuarterly reportPeriod 2025-03-310001448431-25-000005
2025-05-1220:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001448431-25-000003
2025-04-3012:30 ETDEF 14AProxy statementPeriod 2025-06-110001213900-25-037114
2025-04-2118:47 ETSCHEDULE 13D/AOwnership report, active investor, amended0000950170-25-056236
2025-04-1820:30 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001213900-25-033402
2025-03-2020:46 ET10-KAnnual reportPeriod 2024-12-310001213900-25-025576
2025-03-1211:45 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-25-022947
2025-03-1021:29 ETSCHEDULE 13D/AOwnership report, active investor, amended0000950170-25-036537
2025-03-1011:45 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-25-021923
2025-02-0516:41 ETSCHEDULE 13DOwnership report, active investor0000950170-25-014245
2025-01-1021:05 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001213900-25-002644
2024-12-2313:50 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-24-111528
2024-11-1420:30 ET10-QQuarterly reportPeriod 2024-09-300001213900-24-098319
2024-11-1321:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-24-097468
2024-08-1520:30 ET10-QQuarterly reportPeriod 2024-06-300001213900-24-069700
2024-08-0820:25 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-24-066641
2024-06-0720:00 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001213900-24-050753
2024-05-1521:01 ET10-QQuarterly reportPeriod 2024-03-310001213900-24-043749
2024-05-1420:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-24-042937
2024-04-2920:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-24-037205
2024-04-2912:35 ETDEF 14AProxy statementPeriod 2024-06-050001213900-24-036855
2024-04-1820:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-24-034128
2024-04-1520:41 ET10-KAnnual reportPeriod 2023-12-310001213900-24-033000
2024-04-0220:05 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-24-029318
2024-03-1121:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-24-021461
2024-01-2621:00 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-24-006959
2024-01-0522:19 ET8-K/A9.01 Financial statements and exhibits0001213900-24-001616
2023-11-1421:00 ET10-QQuarterly reportPeriod 2023-09-300001213900-23-086885
2023-11-0612:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-23-083645
2023-10-2520:00 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001013762-23-006625
2023-10-1620:31 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001013762-23-004127
2023-08-1420:31 ET10-QQuarterly reportPeriod 2023-06-300001213900-23-067120

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.